OptimizeRx Corp (OPRX) Share-based Payment Arrangement, Expense USD 2021 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
OptimizeRx Corp quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2021 to 2023.
  • OptimizeRx Corp Share-based Payment Arrangement, Expense for the quarter ending March 31, 2023 was $2.91 M, a 28.5% increase year-over-year.
  • OptimizeRx Corp Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2023 was $16.4 M, a 132% increase year-over-year.
  • OptimizeRx Corp annual Share-based Payment Arrangement, Expense for 2022 was $15.7 M, a 187% increase from 2021.
  • OptimizeRx Corp annual Share-based Payment Arrangement, Expense for 2021 was $5.49 M, a 73.1% increase from 2020.
  • OptimizeRx Corp annual Share-based Payment Arrangement, Expense for 2020 was $3.17 M, a 40.4% increase from 2019.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $16.4 M $2.91 M +$645 K +28.5% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-12
Q4 2022 $15.7 M $5.17 M +$2.3 M +79.7% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-10
Q3 2022 $13.5 M $4.28 M +$3.27 M +324% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $10.2 M $4.03 M +$3.13 M +349% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $7.05 M $2.27 M +$1.56 M +221% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 $5.49 M $2.88 M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-10
Q3 2021 $1.01 M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $897 K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $707 K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.